CHF 1535 (BDP + FF) via pMDI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF 1535 (BDP + FF) via pMDI, covering 2018-04-13 to 2018-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma [Phase 3]